BUCCALIN not checked
Laboratorio Farmaceutico SIT srl
FollowEvery change as it happens, and a Monday email
Trials
1 active
1 in total · 1 in the EU
Targets
—
None known yet
What this is
- How it works
- How it works isn't classified yet
- How it’s given
- “Gastro-resistant tablets (mixture of Streptococcus pneumoniae I, II, III, Streptococcus agalactiae, Staphylococcus aureus, Haemophilus influenzae). The recommended dosage is 1 tablet on day 1, 2 tablets on day 2, and 4 tablets on day 3 and should be taken in the morning on an empty stomach.”In the company’s words, NCT06736288 on ClinicalTrials.gov
- Tested for
- Respiratory Infection, Lower Respiratory Tract Infection (LRTI)
- Main trialPhase 4
- “The goal of this clinical trial is to assess if BUCCALIN® works In the Prophylaxis of Recurrent Lower Respiratory Tract Infections (RLRTIS). It will also evaluate the safety of BUCCALIN®. The primary aim is to reduce the number of infection episodes in the treatment period (12 months) in the BUCCALIN® group versus the Placebo group. Patients diagnosed with RLRTIS will be screened for enrolment. Patients will be requested to provide informed consent before the start of the study related assessments. Eligible patients who meet the study inclusion and exclusion criteria will be randomized…”In the company’s words, NCT06736288 on ClinicalTrials.gov
Other drugs for Respiratory Infection
- MaravirocHealthBio, Inc. · Phase 2/3
- IbrutinibJohnson & Johnson (Janssen) · Phase 3
- MM09Inmunotek S.L. · Phase 3
- SHR-1819Hengrui · Phase 3
- StapokibartKeymed Biosciences Co.Ltd · Phase 3
- AxatilimabIncyte · Syndax Pharmaceuticals · Phase 3
Coming up1
- Apr 2027Phase 4 trial completes · ClinicalTrials.gov
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials1
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 4Recruiting | Apr 2027 | Post Authorization Efficacy and Safety Study (PAES) to Confirm and Collect More Clinical Data of Buccalin® Tablets In the Prophylaxis of Recurrent Lower Respiratory Tract Infections (RLRTIs). |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 20 Nov 2026 · EU trials register (CTIS) updated 20 Nov 2026 · openFDA updated 20 Nov 2026